Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 943-956
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.943
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.943
Figure 2 Sources of epigenetic biomarkers of colorectal cancer.
Blood and fecal DNA samples represent available non-invasive sources of epigenetic diagnostic biomarkers of colorectal cancer, such as the analysis of methylation of septin 9 (SEPT9) and vimentin (VIM) genes, respectively. In addition, the analysis of DNA samples from bioptic tumor tissues could be of relevance for the best choice of therapeutic intervention.
- Citation: Coppedè F, Lopomo A, Spisni R, Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol 2014; 20(4): 943-956
- URL: https://www.wjgnet.com/1007-9327/full/v20/i4/943.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.943